Update shared on 11 Nov 2025
Fair value Decreased 4.46%Narrative Update on Global Health: Analyst Price Target Adjustment
Analysts have revised their price target for Global Health downward from $1,460.53 to $1,395.40, citing slightly lower revenue growth and modestly decreased profit margin expectations.
What's in the News
- Medanta has started construction of a new 400+ bed super-specialty hospital in Guwahati. The project aims to deliver advanced healthcare and set new industry benchmarks in Northeast India (Key Developments).
- The upcoming facility will provide a wide range of super-specialties, including organ transplants, advanced cardiac and neuro care, oncology, and robotics-assisted surgeries (Key Developments).
- The expansion project is projected to generate significant employment, with an estimated 5,000 to 7,000 direct and indirect jobs to be created across the region (Key Developments).
- Global Health Limited's Board of Directors has scheduled a meeting for November 7, 2025, to review and approve unaudited financial results for the second quarter and half year ending September 30, 2025 (Key Developments).
Valuation Changes
- Consensus Analyst Price Target has decreased from ₹1,460.53 to ₹1,395.40.
- Discount Rate has increased slightly from 12.73% to 12.76%.
- Revenue Growth projection has declined from 16.34% to 15.36%.
- Net Profit Margin estimate has decreased from 16.21% to 16.02%.
- Future Price-to-Earnings (P/E) Ratio has fallen from 56.86x to 54.65x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.